
Ophthalmic Medical Device Application Developer
Tongbi AI News, Mocular Medical announced on March 15, 2022, that the company received the "Invention Patent Certificate" (Certificate No. 5001646) issued by the State Intellectual Property Office of the People's Republic of China on March 15, 2022. The specific details are as follows:
The announcement pointed out that the acquisition of this invention patent reflects the company's continuous independent research and development capabilities and technological innovation capabilities. At the same time, it is beneficial for the company to further improve its intellectual property protection system, maintain its technological leadership in this field, and has positive significance for the company’s future sustainable innovation and development.
Tongbi Finance Tip: According to publicly available data, Mocular Medical (832652) reported operating revenue of 86,061,844 yuan in 2020, with a net profit attributable to parent company of 18,380,314 yuan, return on net assets of 19.26%, and revenue growth rate of 36.67%. The current sponsoring broker is Caitong Securities, the trading method is block bidding, and it belongs to the Innovation Layer.